Board Member
Cannabist Co Holdings Inc. (CBSTQ)Equibles does not estimate personal net worth.
Get an email with a short summary when Dell Technologies Inc. publishes a filing, an earnings call transcript or a press release.
Get DELL alertsJeff Clarke is recorded as CEO at Dell Technologies Inc. (DELL) and Board Member at Cannabist Co Holdings Inc. (CBSTQ) since January 1, 2020. The newest filing on record that lists Jeff Clarke as Board Member at Cannabist Co Holdings Inc. (CBSTQ) is dated September 3, 2025. Cannabist Co Holdings Inc. reported in an 8-K filed November 13, 2023 that Jeff Clarke was appointed Director, effective November 8, 2023. Jeff Clarke has spoken on 19 earnings calls across 1 company, most recently for Dell Technologies Inc. on March 31, 2027. Dell Technologies Inc. is classified in the Computer Hardware industry within the Technology sector. Cannabist Co Holdings Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Dell Technologies Inc. includes Michael Dell (CEO and Board Member), Michael S. Dell (CEO and Board Member), David Kennedy (CFO) and 7 others.
“At the Meeting, each of the following nine (9) nominees were elected to serve on the Company's board of directors until the next annual meeting of shareholders or until their successors are duly elected or appointed, by a vote held by ballot in respect of each nominee as follows:”
“The first quarter underscored the strength and agility of our operating model and the advantage of our broad portfolio. Our team executed very well in a challenging environment, delivering record revenue and EPS.”
“I am proud of how our team executed across the business, delivering record revenue and record earnings per share. Revenue was $47 billion, up 58%, and earnings per share was $7.04, up 203%.”
“This quarter, we executed very well, achieving growth across our core markets and experiencing unprecedented demand for our AI-optimized servers. Our revenue reached $23.4 billion, up 5%, driven by growth across all of our core markets.”
“We continued to execute well and delivered strong performance in Q3. Revenue was $24.4 billion, up 10%, on strong ISG revenue growth. Diluted EPS was $2.15, up 14%, and cash flow from operations was $1.6 billion.”
“We executed well in Q2, and I'm really proud of our team and our performance. Revenue was $25 billion, up 9%, with another record for our servers and networking business.”
2020-01-01–present
Last confirmed September 3, 2025
Computer Hardware · Technology
CEO
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2020-01-01–present
